Prostacyclin and atherosclerosis
Author:
- R.J. GryglewskiRGR.J. Gryglewski
- 1 January 1979
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 1 (1) , 164-166
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- PGI2 enhanced cAMP content in bovine coronary arteries in the presence of isobutylmethylxanthineNaunyn-Schmiedeberg's Archives of Pharmacology, 1979
- SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLINThe Lancet, 1979
- Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbitsAtherosclerosis, 1978
- Anti-platelet action of intravenous infusion of prostacyclin in manThrombosis Research, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976